Evaluation of resistance as a measure of successful tumor ablation during irreversible electroporation of the pancreas

Journal of the American College of Surgeons

Volumn 218, Issue 2, 2014, Pages 179-187

  Dunki Jacobs, Erik M ^a   Philips, Prejesh ^a   Martin, Robert C G ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CISPLATIN; ERLOTINIB; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; OXALIPLATIN; PACLITAXEL;

ADJUVANT CHEMORADIOTHERAPY; ADVANCED CANCER; ARTICLE; ASCITES; BILE LEAKAGE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEHYDRATION; DISEASE FREE SURVIVAL; ELECTROPORATION; FAILURE TO THRIVE; FOLLOW UP; GRAFT FAILURE; HUMAN; INTRAOPERATIVE PERIOD; IRREVERSIBLE ELECTROPORATION; IRREVERSIBLE ELECTROPORATION DEVICE; KIDNEY FAILURE; LIVER FAILURE; LOCAL FAILURE FREE SURVIVAL; LOCAL RECURRENCE FREE SURVIVAL; LUNG COMPLICATION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS SURGERY; PORTAL VEIN THROMBOSIS; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE ILEUS; POSTOPERATIVE NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL INFECTION; TUMOR ABLATION; TUMOR RESISTANCE;

DFS; DISEASE-FREE SURVIVAL; IRE; IRREVERSIBLE ELECTROPORATION; LAP; LFR; LOCAL FAILURE OR RECURRENCE; LOCALLY ADVANCED PANCREATIC CANCER; RELATIVE RISK; RR;

CATHETER ABLATION; ELECTRIC IMPEDANCE; ELECTROPORATION; FOLLOW-UP STUDIES; HUMANS; MONITORING, INTRAOPERATIVE; PANCREAS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 84892581995     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2013.10.013     Document Type: Article

References (35)

1. E. Neumann, M. Schaefer-Ridder, Y. Wang, and P.H. Hofschneider Gene transfer into mouse lyoma cells by electroporation in high electric fields Embo J 1 1982 841 845
2. L.M. Mir Therapeutic perspectives of in vivo cell electropermeabilization Bioelectrochemistry 53 2001 1 10
3. D.A. Dean Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals Am J Physiol Cell Physiol 289 2005 C233 C245
4. M.J. Jaroszeski, R. Gilbert, C. Nicolau, and R. Heller Delivery of genes in vivo using pulsed electric fields Methods Mol Med 37 2000 173 186
5. A. Gothelf, L.M. Mir, and J. Gehl Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation Cancer Treat Rev 29 2003 371 387
6. M. Bower, L. Sherwood, Y. Li, and R. Martin Irreversible electroporation of the pancreas: definitive local therapy without systemic effects J Surg Oncol 104 2011 22 28
7. K.P. Charpentier, F. Wolf, and L. Noble et al. Irreversible electroporation of the liver and liver hilum in swine HPB: the official journal of the International Hepato Pancreato Biliary Association 13 2011 168 173
8. K.P. Charpentier, F. Wolf, and L. Noble et al. Irreversible electroporation of the pancreas in swine: a pilot study HPB: the official journal of the International Hepato Pancreato Biliary Association 12 2010 348 351
9. U. Cegovnik, and S. Novakovic Setting optimal parameters for in vitro electrotransfection of B16F1, SA1, LPB, SCK, L929 and CHO cells using predefined exponentially decaying electric pulses Bioelectrochemistry 62 2004 73 82
10. M. Pavlin, M. Kanduser, and M. Rebersek et al. Effect of cell electroporation on the conductivity of a cell suspension Biophys J 88 2005 4378 4390
11. D. Cukjati, D. Batiuskaite, and F. Andre et al. Real time electroporation control for accurate and safe in vivo non-viral gene therapy Bioelectrochemistry 70 2007 501 507
12. J. Glahder, B. Norrild, M.B. Persson, and B.R. Persson Transfection of HeLa-cells with pEGFP plasmid by impedance power-assisted electroporation Biotechnol Bioeng 92 2005 267 276
13. A. Ivorra, and B. Rubinsky Electric field modulation in tissue electroporation with electrolytic and non-electrolytic additives Bioelectrochemistry 70 2007 551 560
14. A. Ivorra, and B. Rubinsky In vivo electrical impedance measurements during and after electroporation of rat liver Bioelectrochemistry 70 2007 287 295
15. G. Grafstrom, P. Engstrom, L.G. Salford, and B.R. Persson 99mTc-DTPA uptake and electrical impedance measurements in verification of in vivo electropermeabilization efficiency in rat muscle Cancer Biother Radiopharm 21 2006 623 635
16. K. Kinosita Jr., and T.Y. Tsong Voltage-induced conductance in human erythrocyte membranes Biochim Biophys Acta 554 1979 479 497
17. H. Schmidt, and R. Stampfli [Depolarization by calcium deficiency and its relation to potassium concentration] Helv Physiol Pharmacol Acta 15 1957 200 211
18. R. Stampfli, and M. Willi Membrane potential of a Ranvier node measured after electrical destruction of its membrane Experientia 13 1957 297 298
19. S.B. Dev, D. Dhar, and W. Krassowska Electric field of a six-needle array electrode used in drug and DNA delivery in vivo: analytical versus numerical solution IEEE Trans Biomed Eng 50 2003 1296 1300
20. R.V. Davalos, B. Rubinsky, and D.M. Otten A feasibility study for electrical impedance tomography as a means to monitor tissue electroporation for molecular medicine IEEE Trans Biomed Eng 49 2002 400 403
21. B. Al-Sakere, F. Andre, and C. Bernat et al. Tumor ablation with irreversible electroporation PloS one 2 2007 e1135
22. R.C. Martin Irreversible eectroporation of locally advanced pancreatic head adenocarcinoma J Gastrointest Surg: official journal of the Society for Surgery of the Alimentary Tract 17 2013 1850 1856
23. G. Narayanan, P.J. Hosein, and G. Arora et al. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma J Vasc Interv Radiol 23 2012 1613 1621
24. S. Bagla, and D. Papadouris Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report J Vasc Interv Radiol 23 2012 142 145
25. M.P. Callery, K.J. Chang, and E.K. Fishman et al. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement Ann Surg Oncol 16 2009 1727 1733
26. G.R. Varadhachary, E.P. Tamm, and J.L. Abbruzzese et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy Ann Surg Oncol 13 2006 1035 1046
27. R.C. Martin 2nd, K. McFarland, S. Ellis, and V. Velanovich Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma J Am Coll Surg 215 2012 361 369
28. Martin RC 2nd, McFarland K, Ellis S, Velanovich V. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol 2012 November 6. [Epub ahead of print].
29. M.A. Makary, E.K. Fishman, and J.L. Cameron Resection of the celiac axis for invasive pancreatic cancer J Gastrointest Surg 9 2005 503 507
30. R.C. Martin, C.R. Scoggins, and V. Egnatashvili et al. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes Arch Surg 144 2009 154 159
31. R.J. Anderson, E. Dunki-Jacobs, and G.G. Callender et al. Clinical evaluation of somatostatin use in pancreatic resections: Clinical efficacy or limited benefit? Surgery 154 2013 755 760
32. C.A. Iacobuzio-Donahue, B. Fu, and S. Yachida et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer J Clin Oncol: official journal of the American Society of Clinical Oncology 27 2009 1806 1813
33. K.A. DeBruin, and W. Krassowska Modeling electroporation in a single cell. I. Effects Of field strength and rest potential Biophys J 77 1999 1213 1224
34. M. Pavlin, and D. Miklavcic Theoretical and experimental analysis of conductivity, ion diffusion and molecular transport during cell electroporation-relation between short-lived and long-lived pores Bioelectrochemistry 74 2008 38 46
35. P. Philips, D. Hays, and R.C.G. Martin Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated PloS one 2013 8:e76260